Cargando…

Role of Gut Microbiota in Breast Cancer and Drug Resistance

Breast cancer is the most common malignancy in women worldwide. The cause of cancer is multifactorial. An early diagnosis and the appropriate treatment of cancer can improve the chances of survival. Recent studies have shown that breast cancer is influenced by the microbiota. Different microbial sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viswanathan, Sathiyapriya, Parida, Sheetal, Lingipilli, Bhuvana Teja, Krishnan, Ramalingam, Podipireddy, Devendra Rao, Muniraj, Nethaji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058520/ https://www.ncbi.nlm.nih.gov/pubmed/36986390 http://dx.doi.org/10.3390/pathogens12030468

Ejemplares similares

The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
por: Nandi, Deeptashree, et al.
Publicado: (2023)

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
por: Siddharth, Sumit, et al.
Publicado: (2021)

Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB
por: Nagalingam, Arumugam, et al.
Publicado: (2021)

Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer
por: Muniraj, Nethaji, et al.
Publicado: (2019)

Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment
por: Muniraj, Nethaji, et al.
Publicado: (2020)

Inhibition of Hydrogen Sulfide Production by Gene Silencing Attenuates Inflammatory Activity by Downregulation of NF-κB and MAP Kinase Activity in LPS-Activated RAW 264.7 Cells
por: Badiei, Alireza, et al.
Publicado: (2014)

Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma
por: Siddharth, Sumit, et al.
Publicado: (2019)

IMMU-22. ALLOGENEIC NK CELLS SECRETING IL15 AND RESISTANT TO TGF-β Show Antitumor Activity Against Gliobastoma
por: Muniraj, Nethaji, et al.
Publicado: (2023)

Concomitant analyses of intratumoral microbiota and genomic features reveal distinct racial differences in breast cancer
por: Parida, Sheetal, et al.
Publicado: (2023)

Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice
por: Kuppusamy, Panjamurthy, et al.
Publicado: (2017)

Author Correction: Concomitant analyses of intratumoral microbiota and genomic features reveal distinct racial differences in breast cancer
por: Parida, Sheetal, et al.
Publicado: (2023)

Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes
por: Xie, Bei, et al.
Publicado: (2017)

The Role of Gut Microbiota on Insulin Resistance
por: Caricilli, Andrea M., et al.
Publicado: (2013)

Gut microbiota and obesity: Impact of antibiotics and prebiotics and potential for musculoskeletal health
por: Klancic, Teja, et al.
Publicado: (2020)

Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
por: Gatla, Himavanth Reddy, et al.
Publicado: (2019)

Gut Microbiota and Breast Cancer: The Dual Role of Microbes
por: Álvarez-Mercado, Ana Isabel, et al.
Publicado: (2023)

Human Gut Microbiota and Drug Metabolism
por: Pant, Archana, et al.
Publicado: (2022)

Resistance and Resilience of Fish Gut Microbiota to Silver Nanoparticles
por: Chen, Pubo, et al.
Publicado: (2021)

The Microbiome–Estrogen Connection and Breast Cancer Risk
por: Parida, Sheetal, et al.
Publicado: (2019)

Potential roles of the gut microbiota in the manifestations of drug use disorders
por: Wang, Zhiyan, et al.
Publicado: (2022)

The role of gut microbiota and drug interactions in the development of colorectal cancer
por: Wu, Jinna, et al.
Publicado: (2023)

Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights
por: Parida, Sheetal, et al.
Publicado: (2020)

The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer
por: Parida, Sheetal, et al.
Publicado: (2019)

Effects of Antidiabetic Drugs on Gut Microbiota Composition
por: Montandon, Sophie A., et al.
Publicado: (2017)

The influence of the gut microbiota on the bioavailability of oral drugs
por: Zhang, Xintong, et al.
Publicado: (2021)

The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria
por: Wuethrich, Irene, et al.
Publicado: (2021)

The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome
por: Enright, Elaine F., et al.
Publicado: (2016)

Crosstalk between gut microbiota and antidiabetic drug action
por: Kyriachenko, Yevheniia, et al.
Publicado: (2019)

Gut microbiota and drug-induced liver injury: an update
por: Niu, Meng-Wei, et al.
Publicado: (2020)

Gut Microbiota-Mediated Drug-Drug Interaction between Amoxicillin and Aspirin
por: Zhang, Juanhong, et al.
Publicado: (2019)

Role of Gut Microbiota in Hepatocarcinogenesis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment
por: Laborda-Illanes, Aurora, et al.
Publicado: (2020)

Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions
por: Ma, Zhijun, et al.
Publicado: (2022)

A pertinent approach to solve nonlinear fuzzy integro-differential equations
por: Narayanamoorthy, S., et al.
Publicado: (2016)

Homotopy perturbation method: a versatile tool to evaluate linear and nonlinear fuzzy Volterra integral equations of the second kind
por: Narayanamoorthy, S., et al.
Publicado: (2016)

Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis
por: Parida, Sheetal, et al.
Publicado: (2023)

Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance
por: Carvalho, Bruno Melo, et al.
Publicado: (2013)

Colonization Resistance of the Gut Microbiota against Clostridium difficile
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2015)

Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics
por: Manchia, Mirko, et al.
Publicado: (2021)

Resistance to permethrin alters the gut microbiota of Aedes aegypti
por: Muturi, Ephantus J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_76ihrjlanl0g0gdim32vk46rdu